Navigation Links
Next Generation Sequencing Bioinformatics Heats up: Nearing $1000 Genome Sparks Soaring Data Output
Date:11/12/2013

MOUNTAIN VIEW, Calif., Nov. 12, 2013 /PRNewswire/ -- The decreasing cost of genome sequencing lends momentum to the global next-generation sequencing (NGS) informatics market. As affordability drives adoption of genome sequencing in multiple end-user segments, an enormous output of NGS data to store and analyze is an overwhelming result. While primary and secondary data analysis tools are likely to become a commodity as pipelines standardize, the high-value tertiary data analysis segment used for biological interpretation and clinical reporting will drive revenue growth.

New analysis from Frost & Sullivan's (http://www.lifesciences.frost.com) Global Next Generation Sequencing Informatics Market finds the market earned revenue of $170 million in 2012 and estimates this to reach $580 million in 2018 at an impressive compound annual growth rate (CAGR) of 22.7 percent. The research covers commercial primary and secondary data analysis tools, storage, computing, commercial biological interpretation and reporting tools, NGS informatics services, and laboratory information management systems across North America, Europe, Asia, and rest of world.

For more information on this research, please email Jennifer Carson, Corporate Communications, at jennifer.carson@frost.com, with your full name, company name, job title, telephone number, company e-mail address, company website, city, state and country.

"With sequencing data production forecast to grow at a CAGR of more than 75 percent between 2012 and 2018, researchers will need efficient NGS informatics solutions to manage, analyze and interpret this escalating amount of data," said Frost & Sullivan Life Sciences Senior Industry Analyst Christi Bird. "As the number of applications for NGS continues to grow, the implementation of NGS informatics will go up."

However, customers employ NGS for a broad range of applications, and there is no ideal product for NGS informatics. Therefore, customers may struggle to identify the appropriate tools for their needs. The wide variety of free public domain and commercial tools provided by the 100 plus competitors in this market has also led to low barriers to entry, ever-intensifying competition, and commoditization in certain product segments.

Moreover, given the array of public and open source software available along with readily accessible internal bioinformatics resources, NGS users are often hesitant to make additional investments in commercial informatics tools. Therefore, beyond the challenges of commoditization and standardization, suppliers must convince NGS users their commercial tools are better than free ones.

"As the market matures and informatics prices fall, competitors will rely not just on the expanding volume of users and NGS data developed but also on the high-value interpretation sector of the market to sustain profits globally," opined Bird. "Suppliers that can develop high-value, simple and streamlined turnkey solutions will find success."

Global Next Generation Sequencing Informatics Market is part of the Life Sciences Growth Partnership Service program. Frost & Sullivan's related research services include: Global Mass Spectrometry Markets, Global microRNA Tools and Services Markets, U.S. qPCR and dPCR Instrumentation Markets, and Global Quantitative and dPCR Instrumentation and Consumables Purchasing Trends. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

Connect with us on social media, including Twitter, Facebook, SlideShare, and LinkedIn, for the latest news and updates.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Global Next Generation Sequencing Informatics Market
NC80-52

Contact:
Jennifer Carson
Corporate Communications – North America
P: 210.247.2450
E: jennifer.carson@frost.com

LinkedIn: Transform Health Group
Twitter: @Frost_Sullivan
Facebook: Frost & Sullivan

http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. UbiVac Opens Trial of Next Generation Lung Cancer Vaccine
2. Omeros Announces Positive OMS721 Data in Model of Age-Related Macular Degeneration
3. Life Technologies Ion Torrent Breakthrough Award Honors Discoveries and Genomic Research Fueled by Next-Generation Sequencing
4. Capsugel Previews New Generation, Easy-to-Open Sprinkle Capsule at CPhI Worldwide and AAPS Annual Meeting and Exposition
5. VisionCare Ophthalmic Technologies Secures Up To $15MM To Accelerate Growth Of Its Novel Treatment For Age-Related Macular Degeneration
6. Gentris Corporation Launches Next Generation Human Transcriptome Array
7. Doctor Updates Book on Eyeglass Treatments for Macular Degeneration
8. Hamilton Regional Laboratory Medicine Program Announces Decision to Acquire COPANs WASPLab, the Next Generation Full Laboratory Automation and Digital Bacteriology System
9. Syneron Medical stellt die nächste Generation von Handstücken für die Haarentfernung mit Gentle Pro Laser und elos-Plus-Systemen vor
10. EPGL Medical Invents New Cell Regeneration Technology For Eye Disease
11. ResearchMoz.us: Biotechnology Market By Application (Biopharmacy, Bioservices, Bioagri, Bioindustrial), By Technology (Fermentation, Tissue Regeneration, PCR, Nanobiotechnology, DNA Sequencing & Others) - Global Industry Analysis, Size, Share, Growt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 2017  New research provides evidence that an old drug ... a study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... Parkinson,s disease, the oral drug levodopa has long been considered ... as the disease progresses, the effects of the medication can ...
(Date:4/19/2017)... THOUSAND OAKS, Calif. , April 19, 2017 ... premium industrial buildings it is developing at Conejo ... California , to Atara Biotherapeutics, Inc. ... patients with severe and life-threatening diseases that have ... focus on allogeneic T-cell therapies for cancer, autoimmune ...
(Date:4/18/2017)... MINNEAPOLIS , April 18, 2017 Cogentix ... focused on providing the Urology, Uro/Gyn and Gynecology markets ... for the first quarter ended March 31, 2017 after ... The Company will host a conference call ... day on Tuesday, May 2, 2017 at 4:30 p.m. ...
Breaking Medicine Technology:
(Date:4/26/2017)... (PRWEB) , ... April 26, ... ... which provides an agile ecosystem and domain expertise for sponsors and CROs ... randomization and trial supply management (RTSM) software platform. Bioclinica AGILE RTSM ...
(Date:4/25/2017)... ... 25, 2017 , ... Bellus Medical, a leader in medical ... new class of photodynamic cosmetics (PDC). , Allumera® is the first PDC cream ... of aging, and minimize the appearance of pores – all with minimal downtime ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... they have signed an agreement to be the preferred physical therapy provider for ... and returning them to Derby City CrossFit as quickly and effectively as possible, ...
(Date:4/25/2017)... ... April 25, 2017 , ... A stressful work environment ... can also decrease overall productivity and performance in the workplace. The goal of Clearview ... the last few weeks of April, Clearview Resolution Services will be shutting down the ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from the ... for the 2015-16 school year across Wisconsin’s public schools, charter schools, and private ... patterns in student test score performance, the report’s limited analyses fail to provide ...
Breaking Medicine News(10 mins):